Graft Polymer (UK) Plc

DB:J4I Stock Report

Market Cap: €5.4m

Graft Polymer (UK) Valuation

Is J4I undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of J4I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate J4I's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate J4I's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for J4I?

Key metric: As J4I is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for J4I. This is calculated by dividing J4I's market cap by their current revenue.
What is J4I's PS Ratio?
PS Ratio12.9x
SalesUK£347.00k
Market CapUK£4.48m

Price to Sales Ratio vs Peers

How does J4I's PS Ratio compare to its peers?

The above table shows the PS ratio for J4I vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
BIG1 Bio-Gate
0.8x16.3%€6.3m
BNN BRAIN Biotech
1.2x8.5%€68.8m
NTG Nabaltec
0.6x5.1%€123.6m
2HRA H&R GmbH KGaA
0.1x2.7%€127.3m
J4I Graft Polymer (UK)
12.9xn/a€4.5m

Price-To-Sales vs Peers: J4I is expensive based on its Price-To-Sales Ratio (12.9x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does J4I's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x2.7%US$132.33m
NSAK OTI Greentech
0.03xn/aUS$594.68k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
J4I 12.9xIndustry Avg. 1.0xNo. of Companies4PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: J4I is expensive based on its Price-To-Sales Ratio (12.9x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is J4I's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

J4I PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio12.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate J4I's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Central Asia Metals

UK£278.4m

Operates as a base metals producer.

9C3

UK£1.88

7D

0.5%

1Y

-3.1%

Compañía de Minas BuenaventuraA

US$3.1b

Engages in the exploration, development, construction, and operation of mineral processing business.

MBU

US$11.70

7D

0%

1Y

41.0%

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.55

7D

-4.4%

1Y

-19.9%